Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in IndiaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Fresenius SELabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Fresenius Kabi Oncology Limited (Baddi) with 2 warning letters. The most recent is a warning letter dated Dec 17, 2017: Warning letter: Aseptic processing, Sterility assurance, Out-of-specification.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Dec 17, 2017 | Warning letter: Aseptic processing, Sterility assurance, Out-of-specificationCDER | Warning letters |
| Dec 4, 2017 | Warning letter: Method validation, Out-of-specificationCDER | Warning letters |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built